Pharmacovigilance in Motion: PharmaGuard’s Role in STADA’s Ownership Transition

When Cinven and Bain Capital announced the sale of a majority stake in STADA Arzneimittel AG to CapVest Partners LLP, it marked more than a financial milestone—it triggered a complex compliance journey.

I’m proud that PharmaGuard Consultancy Ltd played a key role in supporting this transition through targeted pharmacovigilance due diligence. From system assessments to governance continuity, our work helped ensure that patient safety and regulatory integrity remains front and centre.

What we delivered:

✔️ Assurance of compliance with MHRA and EMA standards across EU/UK territories

✔️ Early identification and mitigation of pharmacovigilance risks impacting patient safety and business continuity

✔️ Highlighting of critical governance and operational issues to inform strategic decision-making

This wasn’t theory—it was real-world PV leadership, supporting one of the sector’s most high-profile transitions.

If your organisation is preparing for acquisition, restructuring, or portfolio expansion, let’s talk. PharmaGuard offers precision, warmth, and ethical clarity in every engagement. Contact us at info@pharmaguard.co.uk to explore how we can support your next move.

#pharmacovigilance

#duediligence

#pharmaconsulting

#compliance